Trevi Therapeutics
TRVI
TRVI
55 hedge funds and large institutions have $106M invested in Trevi Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
24% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 17
Holders
55
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$97.3K | |
| 2 | +$90.5K | |
| 3 | +$61K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$54.7K |
| 5 |
Jane Street
New York
|
+$53.6K |
Top Sellers
| 1 | -$189K | |
| 2 | -$181K | |
| 3 | -$103K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$72.8K |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
-$59K |